@article{31e314ef44cf46c9b6c111843c1bb042,
title = "Cholesterol crystals associate with coronary plaque vulnerability in vivo",
author = "Yu Kataoka and Rishi Puri and Muhammad Hammadah and Bhanu Duggal and Kiyoko Uno and Kapadia, \{Samir R.\} and Tuzcu, \{E. Murat\} and Nissen, \{Steven E.\} and Nicholls, \{Stephen J.\}",
note = "Funding Information: Please note: Dr Nissen has received research support to perform clinical trials through the Cleveland Clinic Coordinating Center for Clinical Research from Pfizer , AstraZeneca , Novartis , Roche , Daiichi Sankyo , Takeda , Sanofi , Resverlogix , and Eli Lilly ; and is a consultant/advisor for many pharmaceutical companies but requires them to donate all honoraria or consulting fees directly to charity so that he receives neither income nor a tax deduction. Dr Nicholls has received speaking honoraria from AstraZeneca , Pfizer , Merck/Schering-Plough , and Takeda; consulting fees from AstraZeneca, Abbott, AtheroNova, Esperion Therapeutics, Amgen, Eli Lilly, Sanofi Regeneron, Novartis, Omthera Pharmaceuticals, CSL Behring, Boehringer Ingelheim, Pfizer, Merck/Schering-Plough, Takeda, Roche, Novo Nordisk, LipoScience, and Anthera Pharmaceuticals; and research support from Anthera Pharmaceuticals , AstraZeneca , Cerenis Therapeutics , Eli Lilly , Infraredx , Roche , Resverlogix , Novartis , Amgen , and LipoScience . All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. ",
year = "2015",
month = feb,
day = "17",
doi = "10.1016/j.jacc.2014.11.039",
language = "English (US)",
volume = "65",
pages = "630--632",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier Inc.",
number = "6",
}